Prelude Therapeutics Incorporated
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select sol…
Biotechnology
US, Wilmington [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Prelude Therapeutics Incorporated can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDPrelude Therapeutics Incorporated can't present revenue by segment